Levomilnacipran Production Cost Reports

The report provides a detailed analysis essential for establishing a Levomilnacipran production plant. It encompasses all critical aspects necessary for Levomilnacipran production, including the cost of Levomilnacipran production, Levomilnacipran plant cost, Levomilnacipran production costs, and the overall Levomilnacipran production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Levomilnacipran production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Levomilnacipran is a pharmaceutical compound that finds its primary applications in the treatment of mental health disorders. It is mainly used as an antidepressant for the treatment and management of major depressive disorder (MDD) by regulating the levels of serotonin and norepinephrine in the brain. It helps to improve mood, energy levels, and overall emotional well-being. It is also used in clinical research to study its effects on mood disorders, anxiety, and cognitive function. Levomilnacipran is available in oral dosage forms, such as capsules, for safe and controlled administration to patients. It also finds limited applications in experimental studies that explore novel therapies for neuropsychiatric conditions.

The market for Levomilnacipran is driven by its utilisation as a drug in the management of depression and associated mood disorders, which largely boosts its demand in the pharmaceutical industry. Its application as an antidepressant in the treatment of major depressive disorder (MDD) significantly supports its demand in the medical and pharmaceutical industries. Its utilisation in the healthcare sector as part of modern antidepressant therapies, due to its effectiveness in improving mood and daily functioning, further enhances its market expansion.

Additionally, various factors, including the availability and cost of raw materials, compliance with strict pharmaceutical regulations, technological improvements in synthesis and formulation, and environmental considerations, greatly impact industrial Levomilnacipran procurement. Moreover, efficient distribution networks, international trading practices, logistics management, and robust supply-chain reliability play a crucial role in shaping the global market for Levomilnacipran.

Raw Material for Levomilnacipran Production

According to the Levomilnacipran production plant project report, the major raw materials for Levomilnacipran production include (R)-Epichlorohydrin-Phenyl Acetonitrile-Diethylamine- Potassium Phthalimide-Ethanolamine.

Production Process of Levomilnacipran

The extensive Levomilnacipran production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of levomilnacipran begins with the formation of the optically active lactone intermediate through cyclopropanation reaction of (R)-epichlorohydrin with phenyl acetonitrile, followed by lactonisation. The process of cyclopropanation and lactonisation reaction forms the cyclic lactone structure, which sets up the stereocenters needed for the final drug molecule. Then, this lactone is converted to amide alcohol by opening the lactone ring using diethylamine. The primary alcohol is then transformed into an alkyl chloride intermediate, which is reacted with potassium phthalimide to form a phthalimido amide with high overall yield. Further, this intermediate is finally deprotected with ethanolamine to produce levomilnacipran, which is converted into its stable HCl salt using a mixture of HCl, isopropanol, and isopropyl acetate in toluene. The complete process results in the formation of levomilnacipran with high purity as the final product.

Levomilnacipran is a selective serotonin–norepinephrine reuptake inhibitor (SNRI) that appears as an odourless white to off-white crystalline powder. The molecular formula of the compound is C15H22N2, and its molar mass is approximately 246.35 g/mol. The density of the HCl salt is around 1.30 g/cm³. The hydrochloride form of Levomilnacipran is moderately soluble in water (around ≥ 50 mg/mL) and also dissolves in organic solvents such as DMSO, ethanol, and DMF. It is relatively stable when stored at low temperatures (e.g., –20 degree Celsius) in a dry, protected environment. Its pKa value is ~10.36, which shows that it is a basic compound, and Levomilnacipran is a pharmacologically active agent that should be handled with caution in its pure form due to its bioactive and potentially hazardous nature.